company background image
ONCO3 logo

Oncoclínicas do Brasil Serviços Médicos BOVESPA:ONCO3 Stock Report

Last Price

R$8.85

Market Cap

R$4.5b

7D

-9.1%

1Y

8.9%

Updated

29 Mar, 2024

Data

Company Financials +

Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Stock Report

Market Cap: R$4.5b

Oncoclínicas do Brasil Serviços Médicos S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Oncoclínicas do Brasil Serviços Médicos
Historical stock prices
Current Share PriceR$8.85
52 Week HighR$13.00
52 Week LowR$7.67
Beta1.23
1 Month Change-11.59%
3 Month Change-31.92%
1 Year Change8.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO-53.69%

Recent News & Updates

Recent updates

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

Mar 11
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

Feb 17
What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Dec 08
It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Nov 06
Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Shareholder Returns

ONCO3BR HealthcareBR Market
7D-9.1%-4.7%0.7%
1Y8.9%11.8%19.8%

Return vs Industry: ONCO3 underperformed the BR Healthcare industry which returned 10.7% over the past year.

Return vs Market: ONCO3 underperformed the BR Market which returned 17.7% over the past year.

Price Volatility

Is ONCO3's price volatile compared to industry and market?
ONCO3 volatility
ONCO3 Average Weekly Movement6.0%
Healthcare Industry Average Movement6.0%
Market Average Movement4.7%
10% most volatile stocks in BR Market8.1%
10% least volatile stocks in BR Market2.2%

Stable Share Price: ONCO3's share price has been volatile over the past 3 months.

Volatility Over Time: ONCO3's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aBruno Ferrarihttps://www.grupooncoclinicas.com

Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.

Oncoclínicas do Brasil Serviços Médicos S.A. Fundamentals Summary

How do Oncoclínicas do Brasil Serviços Médicos's earnings and revenue compare to its market cap?
ONCO3 fundamental statistics
Market capR$4.50b
Earnings (TTM)R$223.62m
Revenue (TTM)R$5.49b

20.1x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ONCO3 income statement (TTM)
RevenueR$5.49b
Cost of RevenueR$3.56b
Gross ProfitR$1.93b
Other ExpensesR$1.70b
EarningsR$223.62m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 13, 2024

Earnings per share (EPS)0.44
Gross Margin35.14%
Net Profit Margin4.07%
Debt/Equity Ratio154.7%

How did ONCO3 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.